Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fulcrum Therapeutics Inc.

    NASDAQ: FULC · Real-Time Price · USD
    7.24
    -0.14 (-1.90%)
    At close: Jun 27, 2025, 11:06 AM

    Fulcrum Therapeutics Revenue

    Fulcrum Therapeutics reported an annual revenue of $80M, reflecting a 2752.05% growth. For the quarter ending March 31, 2025, Fulcrum Therapeutics generated $0 in revenue.
    Revenue (ttm)
    $80M
    Revenue Growth
    2752.05%
    Price / Sales Ratio
    3.64
    Revenue / Employee
    $1.78M
    Employees
    45
    Market Cap
    390.81M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist